ABSTRACT
Background
Few cessation studies have examined their recruitment methods to determine the most effective methods for enrollment and retention.
Purpose
Data from a randomized controlled trial of yoga for smoking cessation was used to evaluate recruitment methods (e.g., radio, referral) and their relationship to enrollment, participant characteristics, and retention at end of treatment (EOT).
Methods
Screening data from 1065 adults were analyzed for recruitment method, eligibility, randomization, and retention through EOT using Analysis of Variance and Chi-squared tests. Costs per enrolled participant were calculated.
Results
Rates of participant accrual from screening through randomization differed by recruitment method (p < .05), although there were no differences in retention post-randomization. Among randomized participants, the majority were recruited via radio (44%) and the least number via newspaper (5%). There were differences in baseline psychosocial (i.e., nicotine dependence, readiness to quit) and demographic (i.e., age, employment) characteristics of randomized participants (n = 227, 55.5% women) across recruitment methods. Differences in costs between recruitment methods (p < .001) were noted.
Discussion
Recruitment methods differed substantially in their cost and ability to attract individuals who would ultimately enroll.
Translation to Health Education Practice: This investigation highlights the need to combine different recruitment methods to attract diverse individuals into cessation treatments.
A AJHE Self-Study quiz is online for this article via the SHAPE America Online Institute (SAOI) http://portal.shapeamerica.org/trn-Webinars
Disclosure statement
No potential conflict of interest was reported by the authors. All procedures performed in this study were approved by the Institutional Review Board of the Miriam Hospital. All procedures performed instudies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. ClinicalTrials.gov Identifier: NCT01809678.